Clinical Trial Update: A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Pfizer-sponsored Phase I trial evaluating a single intravenous dose of PF-04360365 in adults with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PF-04360365

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED